We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Latest Articles

Chemotyping: Classifying cannabis strains by chemical composition
Article

Grouping strains by chemotyping may prove useful in ascertaining how strains are related, and the kind of medical benefits you can expect to see with strains from a given chemotype class.

READ MORE

Discipline Convergence and the New Manufacturing Paradigm
Article

In many industries, curiosity-driven research is being replaced by purpose-driven research, as scientists must satisfy market-led specifications. Successful predictive science depends on seamless collaboration, unified workflows, comprehensive knowledge, and standardized data that is available and understandable in context.

READ MORE

Navigating Drug Discovery with High-Throughput Screening
Article

Once the preserve of big pharma, high-throughput screening and the data it has produced is now widely available. Together with advances in artificial intelligence, it is providing broad opportunities in drug discovery.

READ MORE

qPortal Offers a Data-Driven Approach to Biomedical Research
Article

We discuss the recently released data management platform qPortal with one of its creators, Christopher Mohr.

READ MORE

Data Visualization Innovations in Life Sciences and Drug Discovery
Article

Around 15 years ago, for biologists awash with data, visualization was often dealt with as an add-on, an afterthought. Fast-forward to today, and data visualization is making something of a comeback. Advances in technology and an increased appreciation of its importance and potential by the life sciences community and funders, are contributing to a renaissance.

READ MORE

Promoting the Use of AI within the Life Sciences Industry
Article

Awareness of Artificial Intelligence (AI), Machine Learning (ML) and Neuro-linguistic Programming (NLP) is ever-increasing, with AI being one of the most talked about technologies across multiple industries. The Pistoia Alliance recently surveyed 374 life science professionals to determine the impact of AI, ML and NLP on the life sciences industry.

READ MORE

Neuroinformatics and The Blue Brain Project
Article

The Blue Brain Project is an attempt to reverse engineer the rodent brain (and ultimately, the human brain) and recreate it at the cellular level inside a computer simulation.

READ MORE

Building the Blue Brain Nexus
Article

The Blue Brain Nexus is designed to facilitate the recording, curating, storing, describing and tracking of experimental and computational neuroscience data in a format that may enable researchers to build a truly comprehensive picture of the brain.

READ MORE

The Viral Genome: Moving Beyond Reading Code – Why Not Rewrite It?
Article

Researchers have discovered how to read, decode, and manipulate previously ‘hidden’ viral code. This could open up new opportunities in drug delivery and gene therapy.

READ MORE

Advancing Drug Discovery Through Academic–Industry Collaboration
Article

Genestack recently announced that they were joining the Milner Therapeutics Institute. In light of the announcement, we spoke to Prof. Tony Kouzarides, Director of the Milner Therapeutics Institute and Dr. Misha Kapushesky, Founder and CEO of Genestack, to learn more.

READ MORE